Form 4: Mirum Pharmaceuticals CFO Buys $49,600 in Company Stock
SEC Form 4 Filing
Eric Bjerkholt, CFO of Mirum Pharmaceuticals, recently purchased 2,000 shares of the company's common stock at $24.80 per share.
Summary
- On March 27, 2024, Eric Bjerkholt, the Chief Financial Officer of Mirum Pharmaceuticals, Inc., purchased 2,000 shares of common stock.
- The purchase price was $24.80 per share.
- Following the transaction, Bjerkholt directly owns 14,000 shares of Mirum Pharmaceuticals.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CFO's stock purchase is a positive signal, but it's a relatively small transaction and doesn't provide definitive insight into the company's overall health.
Positives
- The CFO's purchase of company stock could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. However, it's just one data point and should be considered alongside other factors.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of the stock purchase transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.